Age-related Macular Degeneration 老年性黃斑部病變

COND-amd

4

interventions reviewed

A

top tier

1

counter-evidence

A Moderate evidence 1

Published with Warning ⚠️ 中度市場風險

B Preliminary 2

Disputed 🚨 高市場風險

Published ⚠️ 中度市場風險

D Counter-evidence 1

Insufficient Evidence ⚠️ 中度市場風險